Association between antidepressant side effects and functional impairment in patients with major depressive disorders

Toshiaki Kikuchi, Takefumi Suzuki, Hiroyuki Uchida, Koichiro Watanabe, Masaru Mimura

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Patients with depression may not well be aware of antidepressant adverse events (AEs); however, no studies have assessed how these AEs affect their daily function. Therefore, to evaluate the relationship between the quality of AEs and functional impairment, we studied 482 outpatients with depressive disorders who were not receiving any antidepressant treatment prior to the baseline visit and started it thereafter in usual clinical settings. The Quick Inventory for Depressive Symptomatology Self-Report Japanese version and antidepressant AEs for subjective assessment (antiAS) were performed at baseline and 10 days after antidepressant initiation (i.e. second visit). Functional impairment was evaluated with the Sheehan Disability Scale (SDS) on the second visit. As a result, the SDS was positively associated with the number of AEs (β=0.089, p=0.022) in multiple linear regression analysis (adjusted R2=0.357, p<0.001). Subjects who experienced vertigo, nausea and insomnia had significantly more functional impairment than those who did not. Additionally, the number of severe AEs (β=0.151, p<0.001) was associated with a higher SDS score, and those AEs with a negative causal attribution to antidepressants in the antiAS significantly affected the SDS (β=0.105, p=0.008). AEs of antidepressants should be carefully monitored since they could negatively affect their daily function.

Original languageEnglish
Pages (from-to)127-133
Number of pages7
JournalPsychiatry Research
Volume210
Issue number1
DOIs
Publication statusPublished - 2013 Nov 30

Fingerprint

Major Depressive Disorder
Antidepressive Agents
Vertigo
Sleep Initiation and Maintenance Disorders
Depressive Disorder
Self Report
Nausea
Linear Models
Outpatients
Regression Analysis
Depression
Equipment and Supplies

Keywords

  • Adverse events
  • Antidepressant agents
  • Daily function
  • Depression
  • Recognition
  • Sheehan Disability Scale
  • Underrecognition

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Association between antidepressant side effects and functional impairment in patients with major depressive disorders. / Kikuchi, Toshiaki; Suzuki, Takefumi; Uchida, Hiroyuki; Watanabe, Koichiro; Mimura, Masaru.

In: Psychiatry Research, Vol. 210, No. 1, 30.11.2013, p. 127-133.

Research output: Contribution to journalArticle

@article{1977cfa3646a4d48952c1aca745407a2,
title = "Association between antidepressant side effects and functional impairment in patients with major depressive disorders",
abstract = "Patients with depression may not well be aware of antidepressant adverse events (AEs); however, no studies have assessed how these AEs affect their daily function. Therefore, to evaluate the relationship between the quality of AEs and functional impairment, we studied 482 outpatients with depressive disorders who were not receiving any antidepressant treatment prior to the baseline visit and started it thereafter in usual clinical settings. The Quick Inventory for Depressive Symptomatology Self-Report Japanese version and antidepressant AEs for subjective assessment (antiAS) were performed at baseline and 10 days after antidepressant initiation (i.e. second visit). Functional impairment was evaluated with the Sheehan Disability Scale (SDS) on the second visit. As a result, the SDS was positively associated with the number of AEs (β=0.089, p=0.022) in multiple linear regression analysis (adjusted R2=0.357, p<0.001). Subjects who experienced vertigo, nausea and insomnia had significantly more functional impairment than those who did not. Additionally, the number of severe AEs (β=0.151, p<0.001) was associated with a higher SDS score, and those AEs with a negative causal attribution to antidepressants in the antiAS significantly affected the SDS (β=0.105, p=0.008). AEs of antidepressants should be carefully monitored since they could negatively affect their daily function.",
keywords = "Adverse events, Antidepressant agents, Daily function, Depression, Recognition, Sheehan Disability Scale, Underrecognition",
author = "Toshiaki Kikuchi and Takefumi Suzuki and Hiroyuki Uchida and Koichiro Watanabe and Masaru Mimura",
year = "2013",
month = "11",
day = "30",
doi = "10.1016/j.psychres.2013.05.007",
language = "English",
volume = "210",
pages = "127--133",
journal = "Psychiatry Research",
issn = "0165-1781",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Association between antidepressant side effects and functional impairment in patients with major depressive disorders

AU - Kikuchi, Toshiaki

AU - Suzuki, Takefumi

AU - Uchida, Hiroyuki

AU - Watanabe, Koichiro

AU - Mimura, Masaru

PY - 2013/11/30

Y1 - 2013/11/30

N2 - Patients with depression may not well be aware of antidepressant adverse events (AEs); however, no studies have assessed how these AEs affect their daily function. Therefore, to evaluate the relationship between the quality of AEs and functional impairment, we studied 482 outpatients with depressive disorders who were not receiving any antidepressant treatment prior to the baseline visit and started it thereafter in usual clinical settings. The Quick Inventory for Depressive Symptomatology Self-Report Japanese version and antidepressant AEs for subjective assessment (antiAS) were performed at baseline and 10 days after antidepressant initiation (i.e. second visit). Functional impairment was evaluated with the Sheehan Disability Scale (SDS) on the second visit. As a result, the SDS was positively associated with the number of AEs (β=0.089, p=0.022) in multiple linear regression analysis (adjusted R2=0.357, p<0.001). Subjects who experienced vertigo, nausea and insomnia had significantly more functional impairment than those who did not. Additionally, the number of severe AEs (β=0.151, p<0.001) was associated with a higher SDS score, and those AEs with a negative causal attribution to antidepressants in the antiAS significantly affected the SDS (β=0.105, p=0.008). AEs of antidepressants should be carefully monitored since they could negatively affect their daily function.

AB - Patients with depression may not well be aware of antidepressant adverse events (AEs); however, no studies have assessed how these AEs affect their daily function. Therefore, to evaluate the relationship between the quality of AEs and functional impairment, we studied 482 outpatients with depressive disorders who were not receiving any antidepressant treatment prior to the baseline visit and started it thereafter in usual clinical settings. The Quick Inventory for Depressive Symptomatology Self-Report Japanese version and antidepressant AEs for subjective assessment (antiAS) were performed at baseline and 10 days after antidepressant initiation (i.e. second visit). Functional impairment was evaluated with the Sheehan Disability Scale (SDS) on the second visit. As a result, the SDS was positively associated with the number of AEs (β=0.089, p=0.022) in multiple linear regression analysis (adjusted R2=0.357, p<0.001). Subjects who experienced vertigo, nausea and insomnia had significantly more functional impairment than those who did not. Additionally, the number of severe AEs (β=0.151, p<0.001) was associated with a higher SDS score, and those AEs with a negative causal attribution to antidepressants in the antiAS significantly affected the SDS (β=0.105, p=0.008). AEs of antidepressants should be carefully monitored since they could negatively affect their daily function.

KW - Adverse events

KW - Antidepressant agents

KW - Daily function

KW - Depression

KW - Recognition

KW - Sheehan Disability Scale

KW - Underrecognition

UR - http://www.scopus.com/inward/record.url?scp=84885866529&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885866529&partnerID=8YFLogxK

U2 - 10.1016/j.psychres.2013.05.007

DO - 10.1016/j.psychres.2013.05.007

M3 - Article

C2 - 23742865

AN - SCOPUS:84885866529

VL - 210

SP - 127

EP - 133

JO - Psychiatry Research

JF - Psychiatry Research

SN - 0165-1781

IS - 1

ER -